Will Palantir Crash?
AI and data analytics software major Palantir (NASDAQ:PLTR) has been…
Sell
43
TATT Quote, Financials, Valuation and Earnings
Last price:
$26.30
Seasonality move
:
-2.43%
Day range:
$26.22 - $27.60
52-week range:
$12.61 - $36.49
Dividend yield:
0%
P/E ratio:
22.66x
P/S ratio:
1.82x
P/B ratio:
2.47x
Volume:
244.7K
Avg. volume:
245.1K
1-year change:
75.32%
Market cap:
$287.5M
Revenue:
$152.1M
EPS (TTM):
$1.16
Analysts' Opinion
-
Consensus RatingTAT Technologies has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $35.00, TAT Technologies has an estimated upside of 33.18% from its current price of $26.28.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $34.00 representing 100% downside risk from its current price of $26.28.
Fair Value
-
According to the consensus of 3 analysts, TAT Technologies has 33.18% upside to fair value with a price target of $35.00 per share.
TATT vs. S&P 500
-
Over the past 5 trading days, TAT Technologies has underperformed the S&P 500 by -1.05% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
TAT Technologies does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
TAT Technologies has grown year-over-year revenues for 11 quarters straight. In the most recent quarter TAT Technologies reported revenues of $42.1M.
Earnings Growth
-
TAT Technologies has grown year-over-year earnings for 5 quarters straight. In the most recent quarter TAT Technologies reported earnings per share of $0.34.
Enterprise value:
305.6M
EV / Invested capital:
2.19x
Price / LTM sales:
1.82x
EV / EBIT:
21.27x
EV / Revenue:
1.91x
PEG ratio (5yr expected):
0.26x
EV / Free cash flow:
-21.36x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
15.47x
Gross Profit (TTM):
$35.9M
Return On Assets:
8.24%
Net Income Margin (TTM):
8.04%
Return On Equity:
12.24%
Return On Invested Capital:
10.2%
Operating Margin:
9.9%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $89.8M | $122.7M | $160.2M | $34.1M | $42.1M | |
| Gross Profit | $17.1M | $25.3M | $35.9M | $7.1M | $10M | |
| Operating Income | $1.5M | $7.3M | $14.5M | $2.2M | $4.2M | |
| EBITDA | $5.3M | $12.6M | $19.8M | $3.5M | $5.8M | |
| Diluted EPS | $0.08 | $0.62 | $1.16 | $0.19 | $0.34 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $77.8M | $75M | $74.6M | $90.4M | $119.6M | |
| Total Assets | $114.9M | $116.3M | $125.1M | $140.9M | $170.9M | |
| Current Liabilities | $22.1M | $21.8M | $27.6M | $32.8M | $41.7M | |
| Total Liabilities | $34.1M | $41M | $48.8M | $48.1M | $54.3M | |
| Total Equity | $80.8M | $75.3M | $76.3M | $92.8M | $116.5M | |
| Total Debt | $12.4M | $20M | $26.9M | $22.6M | $23.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $629K | -$3.1M | -$7.3M | -$3.5M | -$5M | |
| Cash From Investing | -$12.1M | -$3.4M | -$7M | $317K | -$2.9M | |
| Cash From Financing | $7.8M | $6.2M | $10.4M | -$4.4M | $5.8M | |
| Free Cash Flow | -$13M | -$8.2M | -$14.3M | -$4.5M | -$7.9M | |
TATT
Sector
Market Cap
$287.5M
$604.4M
Price % of 52-Week High
72.02%
77.78%
Dividend Yield
0%
0%
Shareholder Yield
-2.99%
2.29%
1-Year Price Total Return
75.32%
-2.57%
Beta (5-Year)
0.694
0.775
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$26.40
200-day SMA
Buy
Level
$24.54
Bollinger Bands (100)
Sell
Level
25.68 - 30.9
Chaikin Money Flow
Sell
Level
-37.2M
20-day SMA
Sell
Level
$28.32
Relative Strength Index (RSI14)
Sell
Level
39.49
ADX Line
Sell
Level
20.82
Williams %R
Buy
Level
-88.0778
50-day SMA
Sell
Level
$28.96
MACD (12, 26)
Sell
Level
-1.13
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
80.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.2151)
Buy
CA Score
(Annual)
Level (0.9887)
Sell
Beneish M-Score
(Annual)
Level (-1.6697)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-1.3935)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.
Stock Forecast FAQ
In the current month, TATT has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TATT average analyst price target in the past 3 months is $35.00.
-
Where Will TAT Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that TAT Technologies share price will rise to $35.00 per share over the next 12 months.
-
What Do Analysts Say About TAT Technologies?
Analysts are divided on their view about TAT Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that TAT Technologies is a Sell and believe this share price will drop from its current level to $34.00.
-
What Is TAT Technologies's Price Target?
The price target for TAT Technologies over the next 1-year time period is forecast to be $35.00 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is TATT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for TAT Technologies is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of TATT?
You can purchase shares of TAT Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase TAT Technologies shares.
-
What Is The TAT Technologies Share Price Today?
TAT Technologies was last trading at $26.30 per share. This represents the most recent stock quote for TAT Technologies. Yesterday, TAT Technologies closed at $26.28 per share.
-
How To Buy TAT Technologies Stock Online?
In order to purchase TAT Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Target’s Dividend Worth Buying?
Retail giant Target (NYSE:TGT) has been through an extremely volatile…
Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
49
RGC alert for Jun 17
Regencell Bioscience Holdings [RGC] is up 17.5% over the past day.
Buy
59
SYM alert for Jun 17
Symbotic [SYM] is down 1.48% over the past day.
Sell
43
TNXP alert for Jun 17
Tonix Pharmaceuticals Holding [TNXP] is down 2.03% over the past day.
